Medical Oncology Hematology Consultants (MOHC) ( Site 8002) — Newark, Delaware

Medical Oncology Hematology Consultants (MOHC) ( Site 8002) is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Medical Oncology Hematology Consultants (MOHC) ( Site 8002) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse.

Sponsors: Merck Sharp & Dohme LLC.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Newark

Browse all research sites in Delaware · View every site in Newark

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical Oncology Hematology Consultants (MOHC) ( Site 8002)?

Medical Oncology Hematology Consultants (MOHC) ( Site 8002) has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical Oncology Hematology Consultants (MOHC) ( Site 8002) conducted?

Medical Oncology Hematology Consultants (MOHC) ( Site 8002) has 2 clinical trials on record, with 2 currently active. Their work covers Breast Neoplasms, Lymphoma, Large B-Cell, Diffuse.

Is Medical Oncology Hematology Consultants (MOHC) ( Site 8002) accredited by Crixeo Clinical Trials?

Medical Oncology Hematology Consultants (MOHC) ( Site 8002) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical Oncology Hematology Consultants (MOHC) ( Site 8002)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.